BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28864833)

  • 41. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
    Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
    Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic factors in resected T3 non-small cell lung carcinoma: perineural invasion as a new prognostic factor.
    Demir A; Gunluoglu MZ; Kara HV; Buyukpinarbasili N; Dincer SI
    Thorac Cardiovasc Surg; 2008 Mar; 56(2):93-8. PubMed ID: 18278684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ablative dose proton beam therapy for stage I and recurrent non-small cell lung carcinomas : Ablative dose PBT for NSCLC.
    Lee SU; Moon SH; Cho KH; Pyo HR; Kim JY; Kim DY; Kim TH; Suh YG; Kim YJ
    Strahlenther Onkol; 2016 Sep; 192(9):649-57. PubMed ID: 27282279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer.
    Matsuguma H; Oki I; Nakahara R; Suzuki H; Kasai T; Kamiyama Y; Igarashi S; Mori K; Endo S; Yokoi K
    Ann Thorac Surg; 2013 Jun; 95(6):1878-84. PubMed ID: 23618519
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High expression of CHRNA1 is associated with reduced survival in early stage lung adenocarcinoma after complete resection.
    Chang PM; Yeh YC; Chen TC; Wu YC; Lu PJ; Cheng HC; Lu HJ; Chen MH; Chou TY; Huang CY
    Ann Surg Oncol; 2013 Oct; 20(11):3648-54. PubMed ID: 23775407
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC).
    Rieber J; Deeg A; Ullrich E; Foerster R; Bischof M; Warth A; Schnabel PA; Muley T; Kappes J; Heussel CP; Welzel T; Thomas M; Steins M; Dienemann H; Debus J; Hoffmann H; Rieken S
    Lung Cancer; 2016 Jan; 91():41-7. PubMed ID: 26711933
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection.
    Lee JW; Na JO; Kang DY; Lee SY; Lee SM
    Clin Lung Cancer; 2017 Mar; 18(2):198-206. PubMed ID: 27495385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage IA non-small-cell lung cancer after complete surgical resection.
    Shimada Y; Saji H; Yoshida K; Kakihana M; Honda H; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    J Thorac Oncol; 2012 Aug; 7(8):1263-70. PubMed ID: 22673056
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
    Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
    Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mediastinal lymph node examination and survival in resected early-stage non-small-cell lung cancer in the surveillance, epidemiology, and end results database.
    Osarogiagbon RU; Yu X
    J Thorac Oncol; 2012 Dec; 7(12):1798-1806. PubMed ID: 23154551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of survival in 400 surgically resected non-small cell lung carcinomas: towards a redefinition of the T factor.
    Lyons G; Quadrelli S; Silva C; Vera K; Iotti A; Venditti J; Chertcoff J; Chimondeguy D
    J Thorac Oncol; 2008 Sep; 3(9):989-93. PubMed ID: 18758301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications.
    Andre F; Grunenwald D; Pignon JP; Dujon A; Pujol JL; Brichon PY; Brouchet L; Quoix E; Westeel V; Le Chevalier T
    J Clin Oncol; 2000 Aug; 18(16):2981-9. PubMed ID: 10944131
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surgical resection is justified in non-small cell lung cancer patients with node negative T4 satellite lesions.
    Pennathur A; Lindeman B; Ferson P; Ninan M; Quershi I; Gooding WE; Schuchert M; Christie NA; Landreneau RJ; Luketich JD
    Ann Thorac Surg; 2009 Mar; 87(3):893-9. PubMed ID: 19231415
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical outcome of subcentimeter non-small cell lung cancer after surgical resection: single institution experience of 105 patients.
    Jiang W; Pang X; Xi J; Chen X; Wang Q; Qian C; Fan H
    J Surg Oncol; 2014 Sep; 110(3):233-8. PubMed ID: 24888753
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer.
    Shoji F; Morodomi Y; Akamine T; Takamori S; Katsura M; Takada K; Suzuki Y; Fujishita T; Okamoto T; Maehara Y
    Lung Cancer; 2016 Aug; 98():15-21. PubMed ID: 27393501
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic factors before and after recurrence of resected non-small cell lung cancer.
    Baba T; Uramoto H; Takenaka M; Chikaishi Y; Oka S; Shigematsu Y; Hanagiri T; Tanaka F
    Respir Investig; 2012 Dec; 50(4):151-6. PubMed ID: 23199979
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors of post-recurrence survival in patients with non-small-cell lung cancer initially completely resected.
    Takahashi Y; Horio H; Hato T; Harada M; Matsutani N; Kawamura M
    Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):14-20. PubMed ID: 25878187
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Neutrophil-to-lymphocyte ratio predicts the survival in patients with post-operative recurrence of non-small cell lung cancer].
    Wang X; Li K
    Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):298-302. PubMed ID: 24989918
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Survival following resection of clinically occult N2 non small cell lung cancer.
    Dalton R; Keller S
    J Cardiovasc Surg (Torino); 1994 Dec; 35(6 Suppl 1):13-7. PubMed ID: 7775526
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Study of prognostic factors in patients with stage I non-small cell lung cancer].
    Jiang ZQ; Jiang GL; Shi DR; Zhang RX; Fu XL; Qian H
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):364-8. PubMed ID: 15312349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.